List view / Grid view
8 August 2016 | By St. Jude Children’s Research Hospital
Using vaccines prepared from killed viruses, the scientists targeted an influenza A H1N1 seasonal flu strain, finding that obese mice are not protected against influenza infections through vaccines, raising concerns about vaccine response in obese humans, who are known to be at an increased risk for severe flu...
25 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Scientists have identified three types of vaccine-induced antibodies that can neutralise diverse strains of the flu virus that infect so many each year...
25 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Prokarium announced the award of funding from the UK governments for the development of three new vaccines against Zika, bacterial diarrhoea and plague...
21 July 2016 | By SMi Group
SMi's 5th annual Cancer Vaccines event will showcase 5 key spotlight sessions on the latest advances in vaccine development and cancer therapy breakthroughs when it returns to Central London this autumn...
20 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Scientists have developed the first widely protective vaccine against chlamydia, a common STI that impacts 113 million people each year and can result in infertility...
6 July 2016 | By Victoria White, Digital Content Producer
Sanofi Pasteur has signed a Cooperative Research and Development Agreement with the WRAIR on the co-development of a Zika vaccine candidate...
4 July 2016 | By Victoria White, Digital Content Producer
MIT engineers have developed easily customisable RNA vaccines that can be manufactured in one week and have shown efficacy against ebola and H1N1 influenza...
1 July 2016 | By Victoria White, Digital Content Producer
Researchers have developed an E. coli-based transport capsule designed to help next-generation vaccines do a more effective job than today's immunisations...
